Placebo

15 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Placebo
Treatment and conditionWhere it standsTrials
Placebo for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for depressive disorder, treatment-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for migraine disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Placebo for myositis ossificansPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for parkinson diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for pruritusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for schizophreniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for sexual dysfunctions, psychologicalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for tuberculosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1